title: A profile of gout patients in Sarawak.
abstract: We performed a prospective study of all patients diagnosed with gout and who received treatment in Sarawak General Hospital from 1 July 2010 to 31 December 2010. There was a total of 138 patients in our study of which 92 (66.7%) were from the indigenous populations. They have a mean age of 56.5 ± 12.5 years with a mean duration of illness of 11.6 ± 8.7 years. The mean lag time between symptom onset to the diagnosis of gout was 2.8 ± 4.8 years and a mean lag time to appropriate treatment of gout of 8.8 ± 8.4 years. Sixty-six (47.8%) patients have family history of gout. The common complications of gout in our patients were tophi (47.1%), joint deformities (39.1%), kidney stones (16.7%), and uric acid nephropathy (0.7%). Hospitalization occurred in 93 (67.4%) patients. Gout is a serious medical problem in our centre. Gout affects middle-aged men, especially the indigenous populations. Almost half of our patients have a family history of gout and have tophi formations. Our gout patients have a significant delay in diagnosis and appropriate treatment, thus contributing to more complications and hospitalizations in our centre. There is an urgent need to educate both patients and healthcare workers on gout and its treatment to reduce the burden of chronic gout in Sarawak.
authors.affiliation: Unit of Rheumatology, Department of Medicine, Sarawak General Hospital, Jalan Hospital, 93450 Kuching, Sarawak, East Malaysia. tehchenglay@yahoo.com
authors.forename: C L
authors.initials: CL
authors.lastname: Teh
authors.forename: Y K
authors.initials: YK
authors.lastname: Cheong
authors.forename: H N
authors.initials: HN
authors.lastname: Ling
authors.forename: P L
authors.initials: PL
authors.lastname: Chan
authors.forename: T
authors.initials: T
authors.lastname: Chan
authors.forename: G R
authors.initials: GR
authors.lastname: Ling
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006073:Gout / Q000175:diagnosis* / Q000188:drug therapy; D006074:Gout Suppressants / Q000627:therapeutic use*; D006760:Hospitalization; D006801:Humans; D008296:Malaysia; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies
chemical_list: D006074:Gout Suppressants
references.citation: Ann Rheum Dis. 1997 Jan;56(1):22-6
references.pmid: 9059136
references.citation: Rheumatology (Oxford). 2010 Jan;49(1):141-6
references.pmid: 19933595
references.citation: Arthritis Rheum. 1977 Apr;20(3):895-900
references.pmid: 856219
references.citation: Rheumatology (Oxford). 2010 Jan;49(1):105-11
references.pmid: 19920095
references.citation: Arthritis Res Ther. 2010;12(6):223
references.pmid: 21205285
references.citation: Clin Ther. 2003 Jun;25(6):1593-617
references.pmid: 12860487
references.citation: Curr Rheumatol Rep. 2010 Apr;12(2):118-24
references.pmid: 20425020
references.citation: J Rheumatol. 1994 Feb;21(2):302-6
references.pmid: 8182641
references.citation: J Rheumatol. 2006 Jul;33(7):1346-50
references.pmid: 16821269
references.citation: Curr Med Res Opin. 2010 Dec;26(12):2813-21
references.pmid: 21050059